4591 Ribomic
- 84
- -1-1.18%
Ribomic News
Ribomic: Financial results briefing for the 2nd quarter (interim period) of the fiscal year ending 2025/3 (Q & A)
Ribomic: Financial results briefing materials for the 2nd quarter (interim period) of the fiscal year ending 2025/3
Volume change rate ranking (9 AM slot) - SOMPOHD, KADOKAWA, etc. are ranked.
In the volume change rate ranking, you can understand the market participants' interest in trends such as speculation by comparing the volume of the latest 5-day average with the volume on the delivery date. Top change rate in volume [As of 9:32 on November 20] (comparison of volume with the latest 5-day average) Stock code Stock name Volume 5-day average volume Volume change rate Stock price change rate <7357> Geocode 110,000 1071 85.083 2101.02% 0.072% <9468>
AHC Group, AR Advanced, and others.
A basic agreement has been concluded for a business partnership with Inventec Corporation (Taipei), which is engaged in the manufacturing and sales of electronic equipment such as notebook PCs, servers, and mobile devices, etc.
Port, Wagokoro and others [emerging markets press release]
<153A>Kauris downward revision, current fiscal year operating profit forecast 0.406 billion yen←0.49 billion yen<155A>Introducing the shareholder benefits program for information strategy<2497>Acquired shares of Global Assist Holdings, the holding company of Bestco, which operates UNITED individual tutoring schools, and made it a subsidiary<4255>THECOO revises financial estimates, current fiscal year operating loss forecast -0.17 billion yen←-0.4 billion yen<4371>CCT downward revision, current fiscal year operating profit forecast 2 billion yen←2.398 billion
Ribomic: Confirmatory letter.
Ribomic: Half Year Report - Term 22 (2024/04/01 - 2025/03/31)
Ribomic Sees Reduced Losses in Latest Financial Report
Ribomic 1H Parent Loss Y479.00M Vs Loss Y554.00M
Ribomic Sees FY Loss Y1.40B
Ribomic: Summary of financial results for the 2nd quarter (interim period) of the fiscal year ending 2025/3 [Japanese GAAP] (unconsolidated)
Daiwa House, Idemitsu Kosan, Tokyo Electron Ltd. unsponsored adr, SoftBank Group (12th)
※Please note that the above calendar is subject to change depending on the company's circumstances. --------------------------------------- November 12 (Tuesday) ＜1431＞ Livework ＜146A＞ Colombia ＜148A＞ Hatchwork ＜1491＞ Chugai Mining ＜1605＞ INPEX ＜1663＞ K&O Energy ＜166A＞ Taski HD ＜1770＞ Fujita E
Stocks that moved the previous day part2 lannett co inc, Fit Easy, Cloud W, etc.
Stock Name <Code> 6th closing price ⇒ Significant decrease compared to the previous day <6962> 562 -52 Operating deficit for the first half due to foreign exchange losses being recorded. Duskin <4665> 3770 -278 downward revision of performance and dividend estimates. GREE <3632> 427 -38 turned into an operating deficit in the first quarter. F Sea Sea <7296> 2694 -158 rose sharply on the 5th due to a significant increase in dividends, etc., although it was well received. Kotobuki Spirits <2222> 2049.5 -63.5 feel exhausted due to maintaining the full-year plan, etc.
TOPIX gross index rebounds, the increase narrows after a round of buying.
Tokyo Stock Exchange Growth Market Index 797.12 +4.14 / Volume 0.2 billion 43.61 million shares / Trading value 112.5 billion yen Tokyo Stock Exchange Growth Market 250 Index 621.45 +3.32 / Volume 74.25 million shares / Trading value 67.8 billion yen Today's growth market, both the Growth Market Index and the Growth Market 250 Index rebounded, with 300 gainers, 233 losers, and 54 unchanged. Today's growth market had a firm development. The Dow Jones Index of the U.S. market on the previous 5 days.
Emerging markets stock digest: Cloud W continues to soar significantly, Flutta hits year-to-date high.
<4599> Stem Inc. 366 +11 rebounds significantly after 5 days. Stem Inc. has announced that a patent for the application of a peptide medicine created from the regenerative induction pharmaceutical development candidate Redasemchid (HMGB1), derived from Taiho Pharmaceutical <4507>, which is already under license, has been registered in Japan. The patent secures the potential for the development of therapeutic drugs for inflammatory bowel diseases (ulcerative colitis, Crohn's disease). Redasemchid has effects such as suppressing weight loss in animal models of inflammatory bowel diseases and inhibiting inflammation.
Active and newly listed stocks during the morning session.
*Enplus <6961> 5550 increased by 550, Ichii Securities upgraded its investment rating. *Itoki <7972> 1606 +146, turning to operating profit increase in the third quarter cumulative total. *Kyushu FG <7180> 778 +70.5, upwardly revised performance and dividend financial estimates. *JMDC <4483> 4633 +368, exceeding the previous plan in the first half. *Fujimi Incorporated <5384> 2504 +186, evaluation of significant profit increase in the first half financial results. *Nomura Micro-
Hot stocks digest (morning session): Mercari, Itochu, CloudW, etc.
Ito'oki <7972>: 1606 yen (+146 yen) continued to rise significantly. The company announced its third-quarter financial results the previous day, with cumulative operating profit at 7.81 billion yen, an increase of 8.7% compared to the same period last year, turning from a 2.0% decrease in the first half to an increase. The full-year financial estimate remains at 10 billion yen, a 17.3% increase from the previous year. Sales in the workplace business are progressing well, and it seems that reduced logistics costs have also boosted profits. As for the cumulative performance for the third quarter, both revenue and operating profit are at their highest levels ever.
Renascience, stem inc rim and others
Upward revision, the previous operating profit forecast 0.063 billion yen ← 0.025 billion yen.
RIBOMIC Announces Positive Interim Results From Phase IIa Trial of Umedaptanib Pegol in Achondroplasia Demonstrating Increase in Annualized Growth Rate of up to +4.6 Cm/year in Children 5 Years of Age and Older in the Low Dose Cohort
Steady, steady U.S. stocks are supportive, but the upside may face a heavy development.
[Emerging Markets Individual Stock Strategy]Today's emerging markets are expected to show a strong performance. In the US stock market on the 24th, the Dow Jones Industrial Average rose by 83.57 points (+0.20%) to 42,208.22 points, marking a fourth consecutive day of gains. Expectations of additional interest rate cuts by the end of the year and stimulus measures in China have supported the outlook for global economic recovery, which in turn has boosted stock prices. However, due to the September consumer confidence index falling below expectations, optimism about the economy has waned. This has led to profit-taking sell-offs near record highs for the Dow, causing some stagnation.
Analysis
Price Target
No Data
No Data